![](/img/cover-not-exists.png)
Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study
Scagliotti, Giorgio V., Shuster, Dale, Orlov, Sergey, von Pawel, Joachim, Shepherd, Frances A., Ross, Jeffrey S., Wang, Qiang, Schwartz, Brian, Akerley, WallaceLanguage:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.12.009
Date:
December, 2017
File:
PDF, 478 KB
english, 2017